Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (121-130 of 318) with videos related to

Pageof 32
Sort By:
Cancer Medicine|December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of gliomaTareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
Plos Pathogens|October 12, 2020
Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitisAlexander Lercher, Alexandra M Popa, Csilla Viczenczova, et al.
Journal of Neuro-Oncology|January 25, 2014
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant gliomaBenedikt Wiestler, Alexander Radbruch, Matthias Osswald, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Stroke|June 10, 2020
Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter StudyCarolin Hoyer, Anne Ebert, Hagen B Huttner, et al.
European Radiology|September 22, 2021
Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosisClaudia E Weber, Julia Krämer, Matthias Wittayer, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Multiple Sclerosis and Related Disorders|January 23, 2019
Temporal evolution of acute multiple sclerosis lesions on serial sodium (<sup>23</sup>Na) MRIPhilipp Eisele, Simon Konstandin, Kristina Szabo, et al.
Oncoimmunology|August 17, 2017
K27M-mutant histone-3 as a novel target for glioma immunotherapyKatharina Ochs, Martina Ott, Theresa Bunse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasivenessDieter Lemke, Philipp-Niclas Pfenning, Felix Sahm, et al.
Pageof 32

Showing results (121-130 of 318) with videos related to

Sort By:
Pageof 32
Cancer Medicine|December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of gliomaTareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
Plos Pathogens|October 12, 2020
Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitisAlexander Lercher, Alexandra M Popa, Csilla Viczenczova, et al.
Journal of Neuro-Oncology|January 25, 2014
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant gliomaBenedikt Wiestler, Alexander Radbruch, Matthias Osswald, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Stroke|June 10, 2020
Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter StudyCarolin Hoyer, Anne Ebert, Hagen B Huttner, et al.
European Radiology|September 22, 2021
Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosisClaudia E Weber, Julia Krämer, Matthias Wittayer, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Multiple Sclerosis and Related Disorders|January 23, 2019
Temporal evolution of acute multiple sclerosis lesions on serial sodium (<sup>23</sup>Na) MRIPhilipp Eisele, Simon Konstandin, Kristina Szabo, et al.
Oncoimmunology|August 17, 2017
K27M-mutant histone-3 as a novel target for glioma immunotherapyKatharina Ochs, Martina Ott, Theresa Bunse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasivenessDieter Lemke, Philipp-Niclas Pfenning, Felix Sahm, et al.
Pageof 32